|
|
|
| The key genes in esophageal squamous cell carcinoma screened by bioinformatics |
| ZHAO Fei1 YUAN Zhiqing2 |
1.The Third Clinical College, Xinxiang Medical University, He′nan Province, Xinxiang 453003, China;
2.College of Basic Medicine, Xinxiang Medical University, He′nan Province, Xinxiang 453003, China |
|
|
|
Abstract Objective To provide new ideas for the study of tumor pathogenesis by screening the key genes of esophageal squamous cell carcinoma (ESCC). Methods The gene expression chips of ESCC were retrieved in GEO database. The differential expression genes were analyzed for obtaining common differential genes. GO and KEGG pathway enrichment analysis were performed in DAVID online database. The 10 key genes with the highest link were obtained by String database and Cytoscape software, and verified in the TCGA database. Results A total of 204 differentially expressed genes were screened. GO analysis showed that the biological process was enriched in 163 items, such as cell division, organelle fission, cell cycle, etc. Cytological components were enriched in 48 entries including extracellular, cytoplasmic and organelle lumen. Molecular function enrichment in 46 entries, such as regulating peptidase activity, binding to extracellular matrix, etc. KEGG pathways were enriched in 12 entries, including local adhesion, p53 signaling pathways, mismatch repair, etc. The 10 highest-linked Hub genes were verified to be highly expressed in ESCC by TCGA databases (P ＜ 0.01). Conclusion CDK1, CCNA2, RFC4, CCNB1, TOP2A, AURKA, CDC6, BUB1, BUB1B and PLK1 are the key genes of ESSC, and may be biomarkers and therapeutic targets in ESCC.
|
|
|
|
|
|
[1] McGuire S. World Cancer Report 2014 Geneva，Switzerland：World Health Organization，International Agency for Research on Cancer，WHO Press，2015 [J]. Adv Nutr，2016， 7（1）：418-419.
[2] Edgar R，Domrachev M，Lash AE. Gene expression omnibus：NCBI gene expression and hybridization array data repository [J]. Nucleic Acids Res，2002，30（1）：207-210.
[3] Ritchie ME，Phipson B，Wu D，et al. limma powers differential expression analyses for RNA-sequencing and microarray studies [J]. Nucleic Acids Res，2015，43（7）：e47.
[4] Huang da W，Sherman BT，Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources [J]. Nat Protoc，2009，4（1）：44-57.
[5] Kanehisa M，Goto S. KEGG：kyoto encyclopedia of genes and genomes [J]. Nucleic Acids Res，2000，28（1）：27-30.
[6] Maag Jesper LV. Gganatogram：an R package for modular visualisation of anatograms and tissues based on ggplot2 [J]. F1000 Res，2018，7（1）：15-76.
[7] Chin CH，Chen SH，Wu HH，et al. CytoHubba：identifying hub objects and sub-networks from complex interactome [J]. BMC Syst Biol，2014，8 Suppl 4：S11.
[8] Tang Z，Li C，Kang B，et al. GEPIA：a web server for cancer and normal gene expression profiling and interactive analyses [J]. Nucleic Acids Res，2017，45（W1）：W98-W102.
[9] Consortium GT. The genotype-tissue expression（GTEx）project [J]. Nat Genet，2013，45（6）：580-585.
[10] Su H，Hu N，Yang HH，et al. Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes [J]. Clin Cancer Res，2011，17（9）：2955-2966.
[11] Hu N，Clifford RJ，Yang HH，et al. Genome wide analysis of DNA copy number neutral loss of heterozygosity （CNNLOH） and its relation to gene expression in esop-hageal squamous cell carcinoma [J]. BMC Genomics，2010，11（6）：576.
[12] Lee JJ，Natsuizaka M，Ohashi S，et al. Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis [J]. Carcinogenesis，2010，31（3）：427-434.
[13] Lin G，Chai J，Yuan S，et al. Venn painter：a tool for the comparison and identification of candidate genes based on venn diagrams [J]. PLoS One，2016，11（4）：e0154315.
[14] Evan GI，Vousden KH. Proliferation，cell cycle and apoptosis in cancer [J]. Nature，2001，411（6835）：342-348.
[15] Lietha D，Cai X，Ceccarelli DF，et al. Structural basis for the autoinhibition of focal adhesion kinase [J]. Cell，2007， 129（6）：1177-1187.
[16] Santamaria D，Barriere C，Cerqueira A，et al. Cdk1 is sufficient to drive the mammalian cell cycle [J]. Nature，2007，448（7155）：811-815.
[17] Hansel D，Dhara S，Huang RC，et al. CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target [J]. Am J Surg Pathol，2005，29（2）：390-399.
[18] Hayward D，Alfonso-Perez T，Cundell MJ，et al. CDK1-CCNB1 creates a spindle checkpoint-permissive state by enabling MPS1 kinetochore localization [J]. J Cell Biol，2019，218（4）：1182-1199.
[19] Lee YE，He HL，Lee SW，et al. AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma [J]. Tumour Biol，2014，35（8）：7983-7991.
[20] Nakamura T，Hamada F，Ishidate T，et al. Axin，an inhibitor of the Wnt signalling pathway，interacts with β-catenin，GSK-3b and APC and reduces the β-catenin level [J]. Genes Cells，1998，3（1998）：395-403. |
|
|
|
